Preferred Label : Pegunigalsidase Alfa;

UNII : 8M7V7Q6537;

CAS number : 1644392-61-9;

NCI Metathesaurus CUI : CL1412548;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3483612/fr/elfabrio-pegunigalsidase-alfa-maladie-de-fabry
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
pegunigalsidase alfa
enzyme replacement therapy
infusions, intravenous
enzymes
adult
evaluation of the transparency committee
fabry disease
Pegunigalsidase Alfa

---
https://www.ema.europa.eu/en/medicines/human/EPAR/elfabrio
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Pegunigalsidase Alfa
Pegunigalsidase Alfa
pegunigalsidase alfa
enzyme replacement therapy
adult
fabry disease
infusions, intravenous
product surveillance, postmarketing
pregnancy
breast feeding
drug evaluation, preclinical

---
Nous contacter.
12/12/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.